Lv1
60 积分 2025-10-09 加入
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
8小时前
待确认
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
2天前
已完结
Placebo responses in randomized controlled trials for systemic therapy in atopic dermatitis: A systematic review and meta-analysis
2个月前
已完结
皖公网安备34019202002308
